Genetic and cytometric analyses of subcutaneous adipose tissue in patients with hemophilia and HIV-associated lipodystrophy
Background The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose ti...
Saved in:
Published in | AIDS research and therapy Vol. 19; no. 1; pp. 14 - 10 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
04.03.2022
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1742-6405 1742-6405 |
DOI | 10.1186/s12981-022-00432-9 |
Cover
Abstract | Background
The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients.
Methods
All six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV− healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry.
Results
The time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV.
Conclusions
Our findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes’ sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications. |
---|---|
AbstractList | The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients.
All six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV- healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry.
The time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV.
Our findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes' sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications. Background The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients. Methods All six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV− healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry. Results The time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV. Conclusions Our findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes’ sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications. Background The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients. Methods All six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV- healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry. Results The time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV. Conclusions Our findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes' sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications. Keywords: Human immunodeficiency virus, HIV-associated lipodystrophy, Lipoatrophy, Gene analysis, Adipose-derived stem cell, Macrophage The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients.BACKGROUNDThe authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients.All six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV- healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry.METHODSAll six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV- healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry.The time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV.RESULTSThe time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV.Our findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes' sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications.CONCLUSIONSOur findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes' sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications. The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients. All six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV- healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry. The time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV. Our findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes' sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications. Abstract Background The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the pathophysiological mechanism of HIV-associated lipodystrophy remains to be elucidated, we analyzed subcutaneous adipose tissues from the patients. Methods All six patients had previously been treated with older nucleoside analogue reverse-transcriptase inhibitors (NRTIs; stavudine, didanosine or zidovudine). Abdominal and inguinal subcutaneous fat samples were obtained from the HIV+ patients with hemophilia and HIV− healthy volunteers (n = 6 per group), and analyzed via DNA microarray, real-time PCR, flow cytometry and immunohistochemistry. Results The time from initial NRTI treatment to collecting samples were 21.7 years in average. Cytometric analysis revealed infiltration of inflammatory M1 macrophages into HIV-infected adipose tissue and depletion of adipose-derived stem cells, possibly due to exhaustion following sustained adipocyte death. Genetic analysis revealed that adipose tissue from HIV+ group had increased immune activation, mitochondrial toxicity, chronic inflammation, progressive fibrosis and adipocyte dysfunction (e.g. insulin resistance, inhibited adipocyte differentiation and accelerated apoptosis). Of note, both triglyceride synthesis and lipolysis were inhibited in adipose tissue from patients with HIV. Conclusions Our findings provide important insights into the pathogenesis of HIV-associated lipodystrophy, suggesting that fat redistribution may critically depend on adipocytes’ sensitivity to drug-induced mitochondrial toxicity, which may lead either to atrophy or metabolic complications. |
ArticleNumber | 14 |
Audience | Academic |
Author | Asahi, Rintaro Mashiko, Takanobu Wu, Szu-Hsien Kanayama, Koji Oka, Shinichi Kurisaki, Akira Takada, Hitomi Tsukada, Kunihisa Mori, Masanori Yoshimura, Kotaro |
Author_xml | – sequence: 1 givenname: Takanobu surname: Mashiko fullname: Mashiko, Takanobu organization: Department of Plastic Surgery, Jichi Medical University, Department of Plastic Surgery, University of Tokyo – sequence: 2 givenname: Kunihisa surname: Tsukada fullname: Tsukada, Kunihisa organization: AIDS Clinical Center, National Center for Global Health and Medicine – sequence: 3 givenname: Hitomi surname: Takada fullname: Takada, Hitomi organization: Stem Cell Technologies Laboratory, Graduate School of Biological Sciences, Nara Institute of Science and Technology – sequence: 4 givenname: Szu-Hsien surname: Wu fullname: Wu, Szu-Hsien organization: Department of Plastic Surgery, University of Tokyo – sequence: 5 givenname: Koji surname: Kanayama fullname: Kanayama, Koji organization: Department of Plastic Surgery, University of Tokyo – sequence: 6 givenname: Rintaro surname: Asahi fullname: Asahi, Rintaro organization: Department of Plastic Surgery, Jichi Medical University – sequence: 7 givenname: Masanori surname: Mori fullname: Mori, Masanori organization: Department of Plastic Surgery, Jichi Medical University – sequence: 8 givenname: Akira surname: Kurisaki fullname: Kurisaki, Akira organization: Stem Cell Technologies Laboratory, Graduate School of Biological Sciences, Nara Institute of Science and Technology – sequence: 9 givenname: Shinichi surname: Oka fullname: Oka, Shinichi organization: AIDS Clinical Center, National Center for Global Health and Medicine – sequence: 10 givenname: Kotaro orcidid: 0000-0002-7152-5475 surname: Yoshimura fullname: Yoshimura, Kotaro email: kotaro-yoshimura@umin.ac.jp organization: Department of Plastic Surgery, Jichi Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35246167$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk1-L1DAUxYusuH_0C_ggBUH0oWuSppn2RVgW3R1c0Af1Ndymt9MsmWbsTV0Hv7yZ6bjMiCzSh7bp75wm5ySnyVHve0yS55ydc16qt8RFVfKMCZExJnORVY-SEz6TIlOSFUd7z8fJKdEtY7kSvHiSHOeFkIqr2Uny6wp7DNak0DepWQe_xDBsX8GtCSn1bUpjbcYAPfqRUmjsyhOmwRKNmNo-XUGw2AdK72zo0g6XftVZZ2FreT3_lgGRNxYCNqmL4mZNYYjM-mnyuAVH-Gx3P0u-fnj_5fI6u_l0Nb-8uMmMkjJkpRRqZgpWlFWRS16XrG1BxKXVDKGWqpKQt3zGuJAgGmmUaIrWtGWjcoYsas6S-eTbeLjVq8EuYVhrD1ZvB_yw0DDEDBxqnjNWgylZ0XJZxJ-ZWR6jrRWKhgmJ0SufvMZ-Bes7cO7ekDO9qUVPtehYi97WoquoejepVmO9xMbEuAZwB1M5_NLbTi_8D13GNRecRYPXO4PBfx-Rgl5aMujc1IoWKldcSpGriL6c0AXEBdm-9dHRbHB9oaqqYLwQs0id_4OKV4NLa-I-a20cPxC8ORBEJuDPsICRSH_8PD9kX-2xHYILHXk3But7OgRf7OdyH8if_RmBcgLM4IkGbLWxATY-cbrWPZy5-Ev6X0Xt6qUI9wsc9K0fh3gW6CHVb0N7F_E |
CitedBy_id | crossref_primary_10_1097_PRS_0000000000010872 |
Cites_doi | 10.1038/nm.1964 10.1097/01.qai.0000182230.47819.aa 10.1194/jlr.M000869 10.1016/j.cyto.2011.10.008 10.1189/jlb.0808501 10.1016/S0140-6736(99)06102-4 10.1097/PRS.0b013e31827c6df5 10.1089/scd.2012.0442 10.1038/nature11930 10.1210/jc.2015-3058 10.1038/s41572-020-0181-1 10.1086/518443 10.1002/cphy.c160028 10.1002/cbf.1388 10.1111/j.1365-2133.2009.09272.x 10.1038/nri978 10.1097/00002030-200501030-00002 10.3851/IMP2758 10.1097/00002030-200305020-00005 10.1177/135965350400900412 10.1097/00002030-200005050-00006 10.1097/QAI.0b013e31814b94e2 10.1097/QAD.0000000000000599 10.1097/00002030-200305230-00010 10.1093/infdis/jis205 10.1016/j.cell.2011.09.045 10.1097/00126334-200305010-00004 10.1097/QAD.0b013e32834dcec9 10.1097/01.qai.0000435599.27727.6c 10.1053/meta.2002.34704 10.1097/QAI.0b013e31829bdb67 10.1016/j.cps.2014.12.008 10.1172/JCI28003 10.1016/j.yexcr.2015.07.031 10.1001/archderm.141.10.1220 10.1001/jamadermatol.2016.3827 10.1097/00002030-200212060-00010 10.1007/s00428-002-0667-0 10.1016/j.cmet.2012.01.024 10.1210/jc.2015-4125 10.1093/infdis/jiv274 10.1086/430379 10.1002/jcp.20636 10.1186/1471-2199-7-33 10.1007/s10059-011-2176-y 10.2337/diabetes.54.5.1392 10.1086/599986 10.1016/S0140-6736(02)08094-7 10.1056/NEJM199507133330202 10.1159/000148252 10.1164/ajrccm.157.4.9709126 |
ContentType | Journal Article |
Copyright | The Author(s) 2022 2022. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. |
Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM KPI 7X8 5PM ADTOC UNPAY DOA |
DOI | 10.1186/s12981-022-00432-9 |
DatabaseName | Springerlink CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Global Issues MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Open Access Full Text url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1742-6405 |
EndPage | 10 |
ExternalDocumentID | oai_doaj_org_article_1300bac805f14541bc73043b6e2d024e 10.1186/s12981-022-00432-9 PMC8895510 A699501527 35246167 10_1186_s12981_022_00432_9 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GrantInformation_xml | – fundername: Ministry of Health, Labour and Welfare grantid: Science Research Grants on HIV/AIDS (H25-AIDS-G-001; H28-AIDS-G-002) funderid: http://dx.doi.org/10.13039/501100003478 – fundername: ; grantid: Science Research Grants on HIV/AIDS (H25-AIDS-G-001; H28-AIDS-G-002) |
GroupedDBID | --- 0R~ 23M 2WC 53G 5GY 5VS 6J9 7X7 88E 8C1 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACPRK ACUHS ADBBV ADRAZ ADUKV AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR IHW INH INR ITC KPI KQ8 LK8 M1P M48 M7P M~E N8Y O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ TR2 TUS UKHRP WOQ WOW XSB ~8M AAYXX CITATION -5E -5G -A0 -BR 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM PMFND 7X8 5PM 2VQ 4.4 ADTOC AHSBF C1A EJD H13 IPNFZ RIG UNPAY |
ID | FETCH-LOGICAL-c644t-84267c505895341b80ffa2742b0eab4694a3f170124a2d4c62d5fcf8d630e0953 |
IEDL.DBID | M48 |
ISSN | 1742-6405 |
IngestDate | Wed Aug 27 01:31:34 EDT 2025 Wed Aug 20 00:07:16 EDT 2025 Tue Sep 30 17:00:36 EDT 2025 Fri Sep 05 14:32:33 EDT 2025 Tue Jun 17 21:45:41 EDT 2025 Tue Jun 10 20:08:49 EDT 2025 Fri Jun 27 04:43:54 EDT 2025 Thu May 22 21:21:37 EDT 2025 Thu Jan 02 22:53:43 EST 2025 Wed Oct 01 04:46:41 EDT 2025 Thu Apr 24 23:12:32 EDT 2025 Sat Sep 06 07:29:59 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | HIV-associated lipodystrophy Human immunodeficiency virus Adipose-derived stem cell Lipoatrophy Gene analysis Macrophage |
Language | English |
License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. cc-by |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c644t-84267c505895341b80ffa2742b0eab4694a3f170124a2d4c62d5fcf8d630e0953 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-7152-5475 |
OpenAccessLink | https://doi.org/10.1186/s12981-022-00432-9 |
PMID | 35246167 |
PQID | 2636144236 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_1300bac805f14541bc73043b6e2d024e unpaywall_primary_10_1186_s12981_022_00432_9 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8895510 proquest_miscellaneous_2636144236 gale_infotracmisc_A699501527 gale_infotracacademiconefile_A699501527 gale_incontextgauss_KPI_A699501527 gale_healthsolutions_A699501527 pubmed_primary_35246167 crossref_citationtrail_10_1186_s12981_022_00432_9 crossref_primary_10_1186_s12981_022_00432_9 springer_journals_10_1186_s12981_022_00432_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-03-04 |
PublicationDateYYYYMMDD | 2022-03-04 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-04 day: 04 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | AIDS research and therapy |
PublicationTitleAbbrev | AIDS Res Ther |
PublicationTitleAlternate | AIDS Res Ther |
PublicationYear | 2022 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | L Gibellini (432_CR7) 2015; 337 J Shuck (432_CR12) 2013; 131 JR Koethe (432_CR18) 2017; 7 M Sievers (432_CR17) 2009; 200 K Szade (432_CR27) 2011; 31 ML Batista Jr (432_CR21) 2012; 57 UA Walker (432_CR50) 2014; 19 F Nakagawa (432_CR2) 2012; 26 N Silver (432_CR16) 2006; 7 RK Semple (432_CR40) 2006; 116 I Bogacka (432_CR36) 2005; 54 GA McComsey (432_CR42) 2005; 19 H Yu (432_CR39) 2015; 128 J Couturier (432_CR34) 2015; 29 JR Koethe (432_CR53) 2020; 6 TL Stanley (432_CR45) 2012; 205 T Satoh (432_CR30) 2013; 495 S Leroyer (432_CR49) 2011; 52 GJ Moyle (432_CR51) 2003; 33 HM Lawler (432_CR33) 2016; 101 H Suga (432_CR15) 2009; 161 JM Gallego-Escuredo (432_CR48) 2013; 64 N Friis-Møller (432_CR6) 2003; 17 C Grunfeld (432_CR47) 2007; 46 CL Westhorpe (432_CR28) 2009; 85 M Burnouf (432_CR13) 2005; 141 NP Juffermans (432_CR20) 1998; 157 FG Bechara (432_CR11) 2008; 217 V Jan (432_CR23) 2004; 9 CB Newgard (432_CR37) 2012; 15 CM Shikuma (432_CR26) 2014; 65 T Mashiko (432_CR22) 2015; 42 DC Macallan (432_CR19) 1995; 333 H Eto (432_CR29) 2013; 22 C Hadigan (432_CR44) 2002; 51 K Yoshimura (432_CR14) 2006; 208 S Nishimura (432_CR32) 2009; 15 DL Jacobson (432_CR5) 2005; 40 JP Bastard (432_CR41) 2002; 359 R Gorjao (432_CR43) 2007; 25 K Brinkman (432_CR8) 1999; 354 V Joky (432_CR9) 2002; 16 S Gordon (432_CR24) 2003; 3 A Jaworowski (432_CR25) 2007; 196 LC Howard (432_CR46) 2016; 101 P Barreiro (432_CR52) 2000; 14 PW Mallon (432_CR4) 2003; 17 J Lloreta (432_CR31) 2002; 441 P Bacchetti (432_CR3) 2005; 40 D Ho (432_CR10) 2017; 153 AK Walker (432_CR38) 2011; 147 S Miuma (432_CR1) 2018; 15 DK Thiara (432_CR35) 2015; 212 |
References_xml | – volume: 15 start-page: 914 year: 2009 ident: 432_CR32 publication-title: Nat Med doi: 10.1038/nm.1964 – volume: 40 start-page: 121 year: 2005 ident: 432_CR3 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/01.qai.0000182230.47819.aa – volume: 128 start-page: 2881 year: 2015 ident: 432_CR39 publication-title: J Cell Sci – volume: 52 start-page: 207 year: 2011 ident: 432_CR49 publication-title: J Lipid Res doi: 10.1194/jlr.M000869 – volume: 57 start-page: 9 year: 2012 ident: 432_CR21 publication-title: Cytokine doi: 10.1016/j.cyto.2011.10.008 – volume: 85 start-page: 1027 year: 2009 ident: 432_CR28 publication-title: J Leukoc Biol doi: 10.1189/jlb.0808501 – volume: 354 start-page: 1112 year: 1999 ident: 432_CR8 publication-title: Lancet doi: 10.1016/S0140-6736(99)06102-4 – volume: 131 start-page: 499 year: 2013 ident: 432_CR12 publication-title: Plast Reconstr Surg doi: 10.1097/PRS.0b013e31827c6df5 – volume: 22 start-page: 985 year: 2013 ident: 432_CR29 publication-title: Stem Cells Dev. doi: 10.1089/scd.2012.0442 – volume: 495 start-page: 524 year: 2013 ident: 432_CR30 publication-title: Nature doi: 10.1038/nature11930 – volume: 101 start-page: 151 year: 2016 ident: 432_CR46 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2015-3058 – volume: 6 start-page: 48 year: 2020 ident: 432_CR53 publication-title: Nat Rev Dis Primers doi: 10.1038/s41572-020-0181-1 – volume: 196 start-page: 38 year: 2007 ident: 432_CR25 publication-title: J Infect Dis doi: 10.1086/518443 – volume: 7 start-page: 1339 year: 2017 ident: 432_CR18 publication-title: Compr Physiol doi: 10.1002/cphy.c160028 – volume: 25 start-page: 305 year: 2007 ident: 432_CR43 publication-title: Cell Biochem Funct doi: 10.1002/cbf.1388 – volume: 161 start-page: 819 year: 2009 ident: 432_CR15 publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2009.09272.x – volume: 3 start-page: 23 year: 2003 ident: 432_CR24 publication-title: Nat Rev Immunol doi: 10.1038/nri978 – volume: 19 start-page: 15 year: 2005 ident: 432_CR42 publication-title: AIDS doi: 10.1097/00002030-200501030-00002 – volume: 15 start-page: 2148 year: 2018 ident: 432_CR1 publication-title: Exp Ther Med – volume: 19 start-page: 783 year: 2014 ident: 432_CR50 publication-title: Antivir Ther doi: 10.3851/IMP2758 – volume: 17 start-page: 971 year: 2003 ident: 432_CR4 publication-title: AIDS doi: 10.1097/00002030-200305020-00005 – volume: 9 start-page: 555 year: 2004 ident: 432_CR23 publication-title: Antivir Ther doi: 10.1177/135965350400900412 – volume: 14 start-page: 807 year: 2000 ident: 432_CR52 publication-title: AIDS doi: 10.1097/00002030-200005050-00006 – volume: 46 start-page: 283 year: 2007 ident: 432_CR47 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e31814b94e2 – volume: 29 start-page: 667 year: 2015 ident: 432_CR34 publication-title: AIDS doi: 10.1097/QAD.0000000000000599 – volume: 17 start-page: 1179 year: 2003 ident: 432_CR6 publication-title: AIDS doi: 10.1097/00002030-200305230-00010 – volume: 205 start-page: S383 year: 2012 ident: 432_CR45 publication-title: J Infect Dis doi: 10.1093/infdis/jis205 – volume: 147 start-page: 840 year: 2011 ident: 432_CR38 publication-title: Cell doi: 10.1016/j.cell.2011.09.045 – volume: 33 start-page: 22 year: 2003 ident: 432_CR51 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/00126334-200305010-00004 – volume: 26 start-page: 335 year: 2012 ident: 432_CR2 publication-title: AIDS doi: 10.1097/QAD.0b013e32834dcec9 – volume: 65 start-page: 151 year: 2014 ident: 432_CR26 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/01.qai.0000435599.27727.6c – volume: 51 start-page: 1143 year: 2002 ident: 432_CR44 publication-title: Metabolism doi: 10.1053/meta.2002.34704 – volume: 64 start-page: 142 year: 2013 ident: 432_CR48 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e31829bdb67 – volume: 42 start-page: 181 year: 2015 ident: 432_CR22 publication-title: Clin Plast Surg doi: 10.1016/j.cps.2014.12.008 – volume: 116 start-page: 581 year: 2006 ident: 432_CR40 publication-title: J Clin Invest doi: 10.1172/JCI28003 – volume: 337 start-page: 160 year: 2015 ident: 432_CR7 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2015.07.031 – volume: 141 start-page: 1220 year: 2005 ident: 432_CR13 publication-title: Arch Dermatol doi: 10.1001/archderm.141.10.1220 – volume: 153 start-page: 61 year: 2017 ident: 432_CR10 publication-title: JAMA Dermatol doi: 10.1001/jamadermatol.2016.3827 – volume: 16 start-page: 2447 year: 2002 ident: 432_CR9 publication-title: AIDS doi: 10.1097/00002030-200212060-00010 – volume: 441 start-page: 599 year: 2002 ident: 432_CR31 publication-title: Virchows Arch doi: 10.1007/s00428-002-0667-0 – volume: 15 start-page: 606 year: 2012 ident: 432_CR37 publication-title: Cell Metab doi: 10.1016/j.cmet.2012.01.024 – volume: 101 start-page: 1422 year: 2016 ident: 432_CR33 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2015-4125 – volume: 212 start-page: 1544 year: 2015 ident: 432_CR35 publication-title: J Infect Dis doi: 10.1093/infdis/jiv274 – volume: 40 start-page: 1837 year: 2005 ident: 432_CR5 publication-title: Clin Infect Dis doi: 10.1086/430379 – volume: 208 start-page: 64 year: 2006 ident: 432_CR14 publication-title: J Cell Physiol doi: 10.1002/jcp.20636 – volume: 7 start-page: 33 year: 2006 ident: 432_CR16 publication-title: BMC Mol Biol doi: 10.1186/1471-2199-7-33 – volume: 31 start-page: 497 year: 2011 ident: 432_CR27 publication-title: Mol Cells doi: 10.1007/s10059-011-2176-y – volume: 54 start-page: 1392 year: 2005 ident: 432_CR36 publication-title: Diabetes doi: 10.2337/diabetes.54.5.1392 – volume: 200 start-page: 252 year: 2009 ident: 432_CR17 publication-title: J Infect Dis doi: 10.1086/599986 – volume: 359 start-page: 1026 year: 2002 ident: 432_CR41 publication-title: Lancet doi: 10.1016/S0140-6736(02)08094-7 – volume: 333 start-page: 83 year: 1995 ident: 432_CR19 publication-title: N Engl J Med doi: 10.1056/NEJM199507133330202 – volume: 217 start-page: 244 year: 2008 ident: 432_CR11 publication-title: Dermatology doi: 10.1159/000148252 – volume: 157 start-page: 1328 year: 1998 ident: 432_CR20 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.157.4.9709126 |
SSID | ssj0036215 |
Score | 2.2673826 |
Snippet | Background
The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of... The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of lipodystrophy.... Background The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of... Abstract Background The authors recently performed plastic surgeries for a small number of patients with hemophilia, HIV infection, and morphologic evidence of... |
SourceID | doaj unpaywall pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 14 |
SubjectTerms | Adipose tissues Adipose-derived stem cell Anti-HIV Agents - therapeutic use Complications and side effects DNA, Mitochondrial - analysis DNA, Mitochondrial - metabolism DNA, Mitochondrial - therapeutic use Gene analysis Genetic aspects Health aspects Hemophilia Hemophilia A - complications Hemophilia A - drug therapy HIV infection HIV Infections - complications HIV Infections - drug therapy HIV Infections - pathology HIV-associated lipodystrophy HIV-Associated Lipodystrophy Syndrome - genetics Human immunodeficiency virus Humans Infectious Diseases Lipoatrophy Lipodystrophy Lipodystrophy - chemically induced Lipodystrophy - complications Lipodystrophy - genetics Macrophage Medicine Medicine & Public Health Risk factors Subcutaneous Fat - chemistry Subcutaneous Fat - metabolism Subcutaneous Fat - pathology Virology |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQDzyEEJRXoIBBSBxo1Dxsr3MsiGoLKuJAUW-W7dh0pW2yahKhFX-eGScbbUAqHDhuPF7JM-N52J5vCHmtPbfSQ1piZwWPWepsXDDG4tJkLndmxhKDtcMnn8X8lH0842dbrb7wTVgPD9wz7gCvW4y2MuE-ZZylxoJOstwIl5XgXxxaX3Bjm2Sqt8FglVO-KZGR4qABryYhbYbEK2DQxcXEDQW0_j9t8pZT-v3B5Hhreovc6KqVXv_Qy-WWYzq6S-4MESU97Fdyj1xz1S65fjLcme-S2_3JHO0Lju6Tn4g0DbRUVyW167a-wKZa-BPhSVxDa0-bztgOwkZXdw3V5WJVN462QUZ0UdEBjLWheIpLz91FvcJzGR3-cn78LdaD0F1JlzC5XDftJdCsH5DTow9f38_joQVDbCFQamMJDnxmOfYe5ODvjEy813i7axKnDaTWTOceId0zprOSWZGV3FsvS5EnDqHsHpKdqq7cY0KTwmKRq00sRBQy05KLEsHBmHec84xFJN1IRNkBnxzbZCxVyFOkUL0UFUhRBSmqIiJvxzmrHp3jSup3KOiREpG1wwfQNzXom_qbvkXkBaqJ6stUR_ugDkVR8ASbBEfkVaBAdI0Kn-98113TqE9fjidEbwYiX8MqrR6qIYBXCMg1odybUML2t5Phlxt9VTiEb-aCdqhM5JjtZ7mIyKNef8elQ9jNRCpg9myi2RPeTEeqxXlAH5egCmDII7K_2QNqMHvNlbzfH_fJP4jqyf8Q1VNyMwtbPo8Ttkd22svOPYMQsjXPg7X4BSXrZ-o priority: 102 providerName: Directory of Open Access Journals – databaseName: Springerlink dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEA96gh-I6PlVPTWK4INX7EeSTR_PxWNPOfHBk3sLaZp6C3vtcm2RxX_emTQtW5VDH3czKSQzmY9M5jeEvNYlN7KEsMTMMh6y2JowY4yFRZ7Y1OYzFuVYO3z8WSxO2MdTfuphcrAWZjt_H0vxrgF7JCHghZDJoceF2VVyjYPixed7czEftC7o4ZgPRTF_nTcxPA6f_08tvGWGfn8iOeZJb5EbXbXWmx96tdoyRYd3yR3vQ9KDnun3yBVb7ZLrxz5Lvktu93dxtC8xuk9-IrY00FJdFdRs2voc22jhTwQksQ2tS9p0uenAUbR111BdLNd1Y2nruEKXFfXwqw3Fe1t6Zs_rNd7EaPfJxdG3UHs224KuYHKxadoLoNk8ICeHH77OF6FvuhAacI3aUILJnhmO3QY5WLhcRmWpMZ-bR1bnEEwznZYI4p4wnRTMiKTgpSllIdLIInjdQ7JT1ZV9TGiUGSxrNZEBH0ImWnJRIBwYKy3nPGEBiQeOKOMRybExxkq5yEQK1XNRAReV46LKAvJ2nLPu8TgupX6PjB4pEUvb_QEipvzRdAm9XBsZ8TJmHJZsQOuxNBc2KcCDsQF5gWKi-sLUUSOoA5FlPMK2wAF55SgQT6PCBzvfddc06tOXownRG09U1rBKo339A-wVQnBNKPcmlHDgzWT45SCvCofwlZyTDpWIFOP7JBUBedTL77h0cLSZiAXMnk0ke7I305FqeebwxiWIAqjugOwPZ0B5Rddcuvf74zn5B1Y9-b-vPyU3E3e40zBie2SnvejsM3AP2_y50wu_AMLLWSc priority: 102 providerName: Springer Nature |
Title | Genetic and cytometric analyses of subcutaneous adipose tissue in patients with hemophilia and HIV-associated lipodystrophy |
URI | https://link.springer.com/article/10.1186/s12981-022-00432-9 https://www.ncbi.nlm.nih.gov/pubmed/35246167 https://www.proquest.com/docview/2636144236 https://pubmed.ncbi.nlm.nih.gov/PMC8895510 https://aidsrestherapy.biomedcentral.com/track/pdf/10.1186/s12981-022-00432-9 https://doaj.org/article/1300bac805f14541bc73043b6e2d024e |
UnpaywallVersion | publishedVersion |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1742-6405 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: RBZ dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1742-6405 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: KQ8 dateStart: 20041201 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1742-6405 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: KQ8 dateStart: 20040101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Open Access Full Text customDbUrl: eissn: 1742-6405 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: DOA dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1742-6405 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: ABDBF dateStart: 20040101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1742-6405 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: DIK dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1742-6405 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: GX1 dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1742-6405 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: M~E dateStart: 20040101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1742-6405 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: RPM dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1742-6405 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1742-6405 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1742-6405 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: 8C1 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1742-6405 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: M48 dateStart: 20041201 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Nature HAS Fully OA customDbUrl: eissn: 1742-6405 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: AAJSJ dateStart: 20041201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 1742-6405 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036215 issn: 1742-6405 databaseCode: C6C dateStart: 20041201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZ2kbgIIRi3wCgGIfHAAmliu8kDQl21qSvaNAFFfbMcx9kqdUlpGkHFn-ccJ40WmAYvjRofR7LP3ZfvEPJapVyHKaQluhdxl3WNdiPGmJvEvglM3GNejHeHj0_EcMxGEz7ZIOtyR_UEFlemdlhParyYvfv5ffURFP6DVfhQvC_AZ4WQFENaZRHm3GiTbINn8lHKj1mzqwC22lY0gCDcdwVEKutLNFd-o-WoLJ7_31b7ktv680hls696m9wss7la_VCz2SXXdXiP3K1jTtqvhOQ-2TDZDrlxXO-q75A71dodra4kPSC_EIsaaKnKEqpXy_wCy27hXwQwMQXNU1qUsS4hsDR5WVCVTOd5YejScpFOM1rDtRYU13npubnI57hyo-wnh0ffXFWLhUnoDDonq2K5AJrVQzI-PPg6GLp1kQZXQyi1dENw8T3NsTohB48Yh16aKtz_jT2jYki-mQpSBH33mfITpoWf8FSnYSICzyDY3SOyleWZeUKoF2m8Bqs9DTFH6KuQiwThw1hqOOc-c0h3zRGpawRzLKQxkzaTCYWsuCiBi9JyUUYOedv0mVf4HddS7yOjG0rE3rYv8sWZrFXZbgDGSoceT7uMw5A1WEkWxML4CUQ8xiEvUExkdZG1sSCyL6KIe1hG2CGvLAXib2R4wOdMlUUhP50etYje1ERpDqPUqr4vAXOFkF0tyt0WJRgI3Wp-uZZXiU14qs5Kh_RFgOsBfiAc8riS32boEJgz0RXQu9eS7NbctFuy6bnFJw9BFMDUO2RvrQNyrdfXzv1eoyf_waqn_5zlZ-SWb_U5cD22S7aWi9I8hwhyGXfIZm_Sg99w0O2Q7X5_9GUEz_2Dk9PP8HYgBh27NtOx5uM3MBZtKg |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLagkxgIIRi3wGAGIfHAItLEdp3Hgpja7iIkNrQ3y3GcrVKXVE0qVPHnOce5aAE0wWPr40j2ufv4fCbknc64kRmkJWYUc58NrfFjxpifJqGNbDJiQYK9w8cnYnLGZuf8vGkKK9vb7m1J0llqp9ZSfCzBM0lIfSF5cjhyfnybbEnOBRuQrfF49m3WWmCwyUPeNsj8dWbPCTms_j8t8jWX9Pt1ya5meo9sr_Ol3vzQi8U1t3TwkDxo4kk6rgXgEbll8x1y57ipmO-Q-_W5HK3bjR6Tn4gzDbRU5yk1m6q4wie18CeCk9iSFhkt14lZQ9Boi3VJdTpfFqWlleMQnee0gWItKZ7h0kt7VSzxVEa7T06m333dsNymdAGT001ZrYBm84ScHXw5_TzxmwcYfANhUuVLcN8jw_HlQQ7eLpFBlmms7SaB1Qkk1kxHGQK6h0yHKTMiTHlmMpmKKLAIZPeUDPIit88JDWKDLa4mMBBPyFBLLlKEBmOZ5ZyHzCPDliPKNOjk-EjGQrksRQpVc1EBF5Xjooo98qGbs6yxOW6k_oSM7igRV9v9UawuVKOmrriXaCMDng0ZhyUbsIAsSoQNU4hmrEf2UExU3aTaWQc1FnHMA3wi2CNvHQVia-R4eedCr8tSHX6d9ojeN0RZAas0uumFgL1COK4e5W6PEpTf9IbftPKqcAhvzDnpUKGIMNcPI-GRZ7X8dkuHoJuJoYDZo55k9_amP5LPLx32uARRADPukf1WB1Rj9Mob936_05N_YNWL__v6HtmenB4fqaPpyeFLcjd0ih75Adslg2q1tq8gbKyS142V-AVX2mGI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3rb9MwELdgkwYIIRivwGAGIfFhi5Ymtpt8LI-q7dg0CYb2zXIcZ6vUJVWTCFX889w5DzWAJvjY-hzJvvM9fL7fEfJOpVyHKYQlehhxlw2MdiPGmJvEvglMPGRejLXDJ6dics5mF_xio4rfvnZvU5J1TQOiNGXl0TJJ6yMeiqMCrFQIYTAEUhZTzo1uk-2QRwLCr-3RaPZ11mpj0M8D3hbL_HVmzyBZ3P4_tfOGefr96WSXP71H7lTZUq1_qMViw0SNH5IHjW9JR7UwPCK3TLZLdk6a7PkuuV_f0dG69Ogx-YmY00BLVZZQvS7za2yvhT8RqMQUNE9pUcW6AgfS5FVBVTJf5oWhpeUWnWe0gWUtKN7n0itznS_xhkbZT06m313VsN8kdAGTk3VRroBm_YScjz9_-zhxm2YMrgaXqXRDMOVDzbELIQfLF4demirM88aeUTEE2UwFKYK7-0z5CdPCT3iq0zARgWcQ1O4p2cryzDwn1Is0lrtqT4NvEfoq5CJBmDCWGs65zxwyaDkidYNUjg0zFtJGLKGQNRclcFFaLsrIIQfdnGWN03Ej9QdkdEeJGNv2j3x1KZsjaxN9sdKhx9MB47BkDdqQBbEwfgKejXHIPoqJrAtWO00hRyKKuIftgh3y1lIgzkaGD3kuVVUU8vhs2iN63xClOaxSq6YuAvYKobl6lHs9SlAEujf8ppVXiUP4es5Kh_RFgHG_HwiHPKvlt1s6OOBMDATMHvYku7c3_ZFsfmVxyEMQBVDpDjlsz4BsFGBx494fdufkH1j14v--vk92zj6N5Zfp6fFLcte35zxwPbZHtspVZV6BB1nGrxsl8QsqGmXS |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genetic+and+cytometric+analyses+of+subcutaneous+adipose+tissue+in+patients+with+hemophilia+and+HIV-associated+lipodystrophy&rft.jtitle=AIDS+research+and+therapy&rft.au=Mori%2C+Masanori&rft.au=Mashiko%2C+Takanobu&rft.au=Kurisaki%2C+Akira&rft.au=Wu%2C+Szu-Hsien&rft.date=2022-03-04&rft.pub=BioMed+Central+Ltd&rft.issn=1742-6405&rft.eissn=1742-6405&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12981-022-00432-9&rft.externalDBID=n%2Fa&rft.externalDocID=A699501527 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-6405&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-6405&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-6405&client=summon |